Distribution and functional effects of neuropeptide Y on equine ureteral smooth muscle and resistance arteries.

This research investigates the distribution and effects of neuropeptide Y (NPY) – a neurotransmitter – on the smooth muscle in the ureter and arterial smooth muscles of horses. The findings suggest that the presence of NPY increases muscular activity in both the ureter and arteries, however, it appears to use different mechanisms – or receptors – to do so.

Research Context

• The research in question is a specialized study of the effects of a neurotransmitter known as neuropeptide Y (NPY) on the smooth muscle of a horse’s ureter, and the resistance arteries.
• The motive behind this research is to get a better understanding on how NPY works. This could contribute to a larger body of knowledge about the function of neurotransmitters and possibly lead to advances in animal or human health care.

Methodology

• The distribution of NPY and its associated nerves (NPY-IR nerves) were studied in vitro – in a controlled laboratory setting.
• NPY-IR nerve fibers were found to be distributed all along the ureter, especially the intravesical part where the NPY-IR ganglion cells were also found.
• The researchers also studied the functional effects of NPY and the Y1- and Y2-receptor agonists by observing any changes in the rhythmic contractions and tone of the isolated intravesical ureter.

Key Findings

• NPY didn’t affect the natural tone or the spontaneous rhythmic contractions of the ureter.
• However, it significantly increased the tone and frequency of phasic activities triggered by noradrenaline – a hormone that gets released in response to stress.
• The Y1-receptor agonist, [Leu31,Pro34]NPY, didn’t change the ureter’s basal tone or the contractile activity caused by noradrenaline.
• The Y2-receptor agonist, NPY(13-36), mimicked the enhancing effect of NPY on noradrenaline responses, suggesting that NPY affects responses to noradrenaline via the Y2 receptor.
• For ureteral resistance arteries, NPY triggered concentration-dependent contractions that were inversely linked to the diameter of the arterial lumen.
• Submaximal concentrations of NPY also increased the sensitivity of ureteral arteries to noradrenaline.
• The Y1-receptor agonist, [Leu31,Pro34]NPY, initiated a contractile effect equal to NPY, and increased noradrenaline responses, indicating similar mechanisms at work in these arterioles, but through Y1 receptors.

Conclusion

• The findings suggest that NPY enhances motor activity in both the ureteral and arterial smooth muscles. However, it uses the Y2 receptor in the former, and Y1 receptors in the latter, to mediate these effects.
• This study has broadened our understanding of the function and influence of NPY, and has potential implications for future research into neurotransmitters and nervous system function in animals and humans.